TY - JOUR
T1 - Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected
AU - Ramarathinam, L.
AU - Sarma, S.
AU - Maric, M.
AU - Zhao, M.
AU - Yang, G.
AU - Chen, L.
AU - Liu, Y.
PY - 1995
Y1 - 1995
N2 - Whether tumors of different lineages share common Ags is a critical issue for understanding anti-tumor immune responses and for designing Ag-specific tumor immunotherapy. Because of lack of cross-protection among individually derived tumors, it has been proposed that tumor Ags are specific for individual tumors. Here we show that lack of cross-protection is not due to lack of a shared tumor Ag. Thus, a plasmocytoma J558 transfected with the costimulatory molecule B7 activates a cross-reactive CTL response in vivo. The major Ag recognized by the cross-reactive CTL is P1A, which is expressed in mastocytoma P815, plasmocytoma J558, and fibrosarcoma Meth A. Surprisingly, no significant cross-protection can be detected among P1A- expressing tumors after immunization with either P1A-expressing or B7- transfected P815 cells. Our results demonstrate that multiple lineages of tumors are not cross-protected even though they share a tumor Ag that can be recognized by CTL. These results have important implications for tumor immunotherapy.
AB - Whether tumors of different lineages share common Ags is a critical issue for understanding anti-tumor immune responses and for designing Ag-specific tumor immunotherapy. Because of lack of cross-protection among individually derived tumors, it has been proposed that tumor Ags are specific for individual tumors. Here we show that lack of cross-protection is not due to lack of a shared tumor Ag. Thus, a plasmocytoma J558 transfected with the costimulatory molecule B7 activates a cross-reactive CTL response in vivo. The major Ag recognized by the cross-reactive CTL is P1A, which is expressed in mastocytoma P815, plasmocytoma J558, and fibrosarcoma Meth A. Surprisingly, no significant cross-protection can be detected among P1A- expressing tumors after immunization with either P1A-expressing or B7- transfected P815 cells. Our results demonstrate that multiple lineages of tumors are not cross-protected even though they share a tumor Ag that can be recognized by CTL. These results have important implications for tumor immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0028859570&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028859570&partnerID=8YFLogxK
M3 - Article
C2 - 7594546
AN - SCOPUS:0028859570
SN - 0022-1767
VL - 155
SP - 5323
EP - 5329
JO - Journal of Immunology
JF - Journal of Immunology
IS - 11
ER -